10-Q Filing

RIOT PLATFORMS, INC. CIK: 1167419 Q3 2016

Filing Information

Form Type	10-Q
Accession Number	`0001079973-16-001292`
Period End Date	20160930
Filing Date	20161114
Fiscal Year	2016
Fiscal Period	Q3
XBRL Instance	appy-20160930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 69 Cash Flow Statement 64

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockNoParValue`	-	USD	Point-in-time
Common stock, par value	`CommonStockNoParValue`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	60.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	60.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.01M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.45M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.23M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.54M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	3.88M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	4.50M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	3.88M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	4.50M	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$14.15M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$12.42M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$21.51K	USD	Point-in-time
Inventories (Note 2)	`InventoryNet`	$412.11K	USD	Point-in-time
Inventories (Note 2)	`InventoryNet`	-	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$322.87K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$251.78K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$15.62M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$16.41M	USD	Point-in-time
Property and equipment, net (Note 3)	`PropertyPlantAndEquipmentNet`	$1.95M	USD	Point-in-time
Property and equipment, net (Note 3)	`PropertyPlantAndEquipmentNet`	$95.39K	USD	Point-in-time
Intangible rights acquired (Note 2)	`IntangibleAssetsNetExcludingGoodwill`	-	USD	Point-in-time
Intangible rights acquired (Note 2)	`IntangibleAssetsNetExcludingGoodwill`	$2.29M	USD	Point-in-time
Long-term investments (Note 1)	`LongTermInvestments`	-	USD	Point-in-time
Long-term investments (Note 1)	`LongTermInvestments`	$972.00K	USD	Point-in-time
Other long term assets, net (Notes 1 and 4)	`OtherAssetsNoncurrent`	$1.52M	USD	Point-in-time
Other long term assets, net (Notes 1 and 4)	`OtherAssetsNoncurrent`	$1.32M	USD	Point-in-time
Total assets	`Assets`	$20.86M	USD	Point-in-time
Total assets	`Assets`	$19.32M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$297.04K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$701.06K	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$449.87K	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$329.10K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$241.88K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$233.51K	USD	Point-in-time
Notes and other obligations, current portion (Note 5)	`NotesPayableCurrent`	$222.13K	USD	Point-in-time
Notes and other obligations, current portion (Note 5)	`NotesPayableCurrent`	$301.25K	USD	Point-in-time
Deferred revenue, current portion (Note 8)	`DeferredRevenueCurrent`	$96.70K	USD	Point-in-time
Deferred revenue, current portion (Note 8)	`DeferredRevenueCurrent`	$96.70K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.79M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.18M	USD	Point-in-time
Notes and other obligations, less current portion (Note 5)	`LongTermNotesPayable`	$1.84M	USD	Point-in-time
Notes and other obligations, less current portion (Note 5)	`LongTermNotesPayable`	-	USD	Point-in-time
Deferred revenue, less current portion (Note 8)	`DeferredRevenueNoncurrent`	$1.16M	USD	Point-in-time
Deferred revenue, less current portion (Note 8)	`DeferredRevenueNoncurrent`	$1.09M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.27M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.79M	USD	Point-in-time
Commitments and contingencies (Notes 8 and 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 8 and 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, no par value, 60,000,000 shares authorized; 4,503,971 and 3,876,961 shares issued and outstanding	`CommonStocksIncludingAdditionalPaidInCapital`	$124.60M	USD	Point-in-time
Common stock, no par value, 60,000,000 shares authorized; 4,503,971 and 3,876,961 shares issued and outstanding	`CommonStocksIncludingAdditionalPaidInCapital`	$121.65M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-105.58M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-107.57M	USD	Point-in-time
Total Venaxis stockholders' equity	`StockholdersEquity`	$16.07M	USD	Point-in-time
Total Venaxis stockholders' equity	`StockholdersEquity`	$17.03M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	-	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$25.02K	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$17.05M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.07M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$19.32M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$20.86M	USD	Point-in-time

Income Statement 69 line items

Line Item	Tag	Value	Unit	Period
Sales (Note 1)	`SalesRevenueGoodsNet`	$92.89K	USD	3 Qtrs
Sales (Note 1)	`SalesRevenueGoodsNet`	$1.92K	USD	3 Qtrs
Sales (Note 1)	`SalesRevenueGoodsNet`	$1.92K	USD	1 Quarter
Sales (Note 1)	`SalesRevenueGoodsNet`	$57.09K	USD	1 Quarter
Cost of sales	`CostOfGoodsSold`	$14.53K	USD	1 Quarter
Cost of sales	`CostOfGoodsSold`	$26.64K	USD	3 Qtrs
Cost of sales	`CostOfGoodsSold`	$1.57K	USD	3 Qtrs
Cost of sales	`CostOfGoodsSold`	$1.57K	USD	1 Quarter
Gross profit	`GrossProfit`	$356.00	USD	1 Quarter
Gross profit	`GrossProfit`	$66.26K	USD	3 Qtrs
Gross profit	`GrossProfit`	$42.56K	USD	1 Quarter
Gross profit	`GrossProfit`	$356.00	USD	3 Qtrs
Other revenue - fee (Note 8)	`LicensesRevenue`	$72.52K	USD	3 Qtrs
Other revenue - fee (Note 8)	`LicensesRevenue`	$72.52K	USD	3 Qtrs
Other revenue - fee (Note 8)	`LicensesRevenue`	$24.18K	USD	1 Quarter
Other revenue - fee (Note 8)	`LicensesRevenue`	$24.18K	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.57M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$1.23M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$4.25M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$1.72M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$426.26K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.69M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$54.46K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$500.13K	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$4.07M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$5.94M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$1.66M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.77M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-1.59M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.00M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-1.75M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-5.80M	USD	3 Qtrs
Gain on sale of property and equipment (Note 3)	`GainLossOnSaleOfPropertyPlantEquipment`	$1.93M	USD	3 Qtrs
Gain on sale of property and equipment (Note 3)	`GainLossOnSaleOfPropertyPlantEquipment`	$13.06K	USD	1 Quarter
Gain on sale of property and equipment (Note 3)	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	1 Quarter
Gain on sale of property and equipment (Note 3)	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	3 Qtrs
Gain on sale of property and equipment (Note 3)	`GainLossOnSaleOfPropertyPlantEquipment`	$1.90M	USD	Point-in-time
Interest expense	`InterestExpense`	$2.38K	USD	1 Quarter
Interest expense	`InterestExpense`	$74.65K	USD	3 Qtrs
Interest expense	`InterestExpense`	$25.39K	USD	1 Quarter
Interest expense	`InterestExpense`	$28.13K	USD	3 Qtrs
Investment income	`InvestmentIncomeNet`	$103.03K	USD	3 Qtrs
Investment income	`InvestmentIncomeNet`	$32.94K	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$23.64K	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$69.15K	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$2.01M	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$34.32K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-5.50K	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$7.55K	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.80M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-1.99M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-1.71M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.58M	USD	1 Quarter
Net loss attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net loss attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.15K	USD	3 Qtrs
Net loss attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.15K	USD	1 Quarter
Net loss attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Net loss attributable to Venaxis, Inc.	`NetIncomeLoss`	$-1.99M	USD	3 Qtrs
Net loss attributable to Venaxis, Inc.	`NetIncomeLoss`	$-1.71M	USD	1 Quarter
Net loss attributable to Venaxis, Inc.	`NetIncomeLoss`	$-5.80M	USD	3 Qtrs
Net loss attributable to Venaxis, Inc.	`NetIncomeLoss`	$-1.58M	USD	1 Quarter
Basic and diluted net loss per share (Note 1)	`EarningsPerShareBasicAndDiluted`	$-0.51	USD	3 Qtrs
Basic and diluted net loss per share (Note 1)	`EarningsPerShareBasicAndDiluted`	$-0.41	USD	1 Quarter
Basic and diluted net loss per share (Note 1)	`EarningsPerShareBasicAndDiluted`	$-0.43	USD	1 Quarter
Basic and diluted net loss per share (Note 1)	`EarningsPerShareBasicAndDiluted`	$-1.50	USD	3 Qtrs
Basic and diluted weighted average number of shares outstanding (Note 1)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.00M	shares	1 Quarter
Basic and diluted weighted average number of shares outstanding (Note 1)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.88M	shares	1 Quarter
Basic and diluted weighted average number of shares outstanding (Note 1)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.92M	shares	3 Qtrs
Basic and diluted weighted average number of shares outstanding (Note 1)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.88M	shares	3 Qtrs

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-1.71M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.58M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.99M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-5.80M	USD	3 Qtrs
Stock-based compensation for services	`ShareBasedCompensation`	$368.46K	USD	3 Qtrs
Stock-based compensation for services	`ShareBasedCompensation`	$1.02M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$97.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$194.44K	USD	3 Qtrs
Amortization of license fees	`RecognitionOfDeferredRevenue`	$24.18K	USD	1 Quarter
Amortization of license fees	`RecognitionOfDeferredRevenue`	$72.52K	USD	3 Qtrs
Amortization of license fees	`RecognitionOfDeferredRevenue`	$72.52K	USD	3 Qtrs
Amortization of license fees	`RecognitionOfDeferredRevenue`	$24.18K	USD	1 Quarter
Other non-cash charges	`OtherNoncashExpense`	$4.65K	USD	3 Qtrs
Other non-cash charges	`OtherNoncashExpense`	$200.38K	USD	3 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$1.93M	USD	3 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$13.06K	USD	1 Quarter
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	3 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$1.90M	USD	Point-in-time
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$602.00	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$59.68K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-224.25K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-236.82K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-225.32K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-521.60K	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedSalaries`	$-120.78K	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedSalaries`	$-430.21K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-94.87K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-81.00K	USD	3 Qtrs
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.84M	USD	3 Qtrs
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-5.22M	USD	3 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$21.21M	USD	3 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$13.82M	USD	3 Qtrs
Sales of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$26.51M	USD	3 Qtrs
Sales of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$16.52M	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$1.80M	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$1.70M	USD	Point-in-time
Purchases of patent and trademark application costs	`PaymentsToAcquireIntangibleAssets`	$59.91K	USD	3 Qtrs
Purchases of patent and trademark application costs	`PaymentsToAcquireIntangibleAssets`	$14.38K	USD	3 Qtrs
Cash acquired in purchase of BiOptix	`CashAcquiredFromAcquisition`	-	USD	3 Qtrs
Cash acquired in purchase of BiOptix	`CashAcquiredFromAcquisition`	$16.67K	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$4.51M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$5.24M	USD	3 Qtrs
Repayment of notes payable and other obligations	`RepaymentsOfNotesPayable`	$229.24K	USD	3 Qtrs
Repayment of notes payable and other obligations	`RepaymentsOfNotesPayable`	$330.14K	USD	3 Qtrs
Net cash (used in) financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-229.24K	USD	3 Qtrs
Net cash (used in) financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-330.14K	USD	3 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$435.04K	USD	3 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-309.60K	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.01M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.45M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.23M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.54M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.01M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.45M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.23M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.54M	USD	Point-in-time
Cash paid during the period for interest	`InterestPaid`	$33.33K	USD	3 Qtrs
Cash paid during the period for interest	`InterestPaid`	$74.94K	USD	3 Qtrs
Liability payoffs upon property sale	`LiabilityPayoffsUponPropertySale`	-	USD	3 Qtrs
Liability payoffs upon property sale	`LiabilityPayoffsUponPropertySale`	$2.06M	USD	3 Qtrs
Value of Common Shares issued for BiOptix purchase	`StockIssued1`	$2.58M	USD	3 Qtrs
Value of Common Shares issued for BiOptix purchase	`StockIssued1`	-	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.